Willow Biosciences to start pilot production of biosynthetic CBG in Q3 18-Aug-2020 By Stephen Daniells Canada-based Willow Biosciences Inc. has announced it will soon start to deliver its first samples of “ultra-pure, pharmaceutical grade” cannabigerol (CBG) from its 500-liter pilot production run.